Pfam Domains GO Terms
| Sox N |
| HMG box |
| regulation of cell proliferation involved in tissue homeostasis |
| epithelial cell proliferation involved in prostatic bud elongation |
| epithelial cell proliferation involved in prostate gland development |
| intrahepatic bile duct development |
| germ-line sex determination |
| bronchus cartilage development |
| primary prostatic bud elongation |
| male germ-line sex determination |
| lung smooth muscle development |
| primary sex determination, germ-line |
| neural crest cell fate specification |
| renal vesicle induction |
| ureter smooth muscle development |
| retinal rod cell differentiation |
| primary sex determination |
| ureter urothelium development |
| ureter smooth muscle cell differentiation |
| prostate gland morphogenetic growth |
| positive regulation of mesenchymal stem cell differentiation |
| Harderian gland development |
| metanephric nephron tubule formation |
| astrocyte fate commitment |
| neural crest cell fate commitment |
| intestinal epithelial structure maintenance |
| common bile duct development |
| stem cell fate specification |
| chondrocyte hypertrophy |
| cellular response to heparin |
| anterior head development |
| positive regulation of extracellular matrix assembly |
| metanephric tubule formation |
| regulation of branching involved in lung morphogenesis |
| response to heparin |
| positive regulation of cell proliferation involved in heart morphogenesis |
| regulation of mesenchymal stem cell differentiation |
| regulation of epithelial cell proliferation involved in lung morphogenesis |
| ureter morphogenesis |
| lacrimal gland development |
| response to anticoagulant |
| otic vesicle formation |
| positive regulation of male gonad development |
| metanephric nephron tubule morphogenesis |
| negative regulation of photoreceptor cell differentiation |
| trachea cartilage development |
| pre-mRNA intronic binding |
| otic vesicle morphogenesis |
| regulation of male gonad development |
| regulation of extracellular matrix assembly |
| stem cell fate commitment |
| regulation of photoreceptor cell differentiation |
| bronchus development |
| negative regulation of mesenchymal cell apoptotic process |
| metanephric tubule morphogenesis |
| prostate gland growth |
| positive regulation of gonad development |
| limb bud formation |
| neural crest formation |
| regulation of mesenchymal cell apoptotic process |
| protein kinase A catalytic subunit binding |
| heart valve formation |
| negative regulation of pri-miRNA transcription by RNA polymerase II |
| Sertoli cell development |
| otic vesicle development |
| glial cell fate commitment |
| male sex determination |
| ureter development |
| metanephric nephron tubule development |
| enhancer binding |
| regulation of cell proliferation involved in heart morphogenesis |
| nephron tubule formation |
| metanephric nephron epithelium development |
| smooth muscle tissue development |
| branch elongation of an epithelium |
| positive regulation of branching involved in ureteric bud morphogenesis |
| metanephric tubule development |
| negative regulation of bone mineralization |
| regulation of gonad development |
| camera-type eye photoreceptor cell differentiation |
| maintenance of gastrointestinal epithelium |
| trachea development |
| metanephric nephron morphogenesis |
| Sertoli cell differentiation |
| cartilage condensation |
| notochord development |
| lung epithelial cell differentiation |
| cell aggregation |
| positive regulation of mesonephros development |
| lung cell differentiation |
| metanephric epithelium development |
| positive regulation of chondrocyte differentiation |
| positive regulation of extracellular matrix organization |
| positive regulation of stem cell differentiation |
| prostate gland epithelium morphogenesis |
| regulation of branching involved in ureteric bud morphogenesis |
| negative regulation of chondrocyte differentiation |
| sex determination |
| enhancer sequence-specific DNA binding |
| prostate gland morphogenesis |
| cochlea morphogenesis |
| nuclear transcription factor complex |
| regulation of mesonephros development |
| bHLH transcription factor binding |
| positive regulation of mesenchymal cell proliferation |
| negative regulation of myoblast differentiation |
| epithelial tube branching involved in lung morphogenesis |
| developmental induction |
| metanephros morphogenesis |
| axis elongation |
| epithelial structure maintenance |
| negative regulation of cartilage development |
| ERK1 and ERK2 cascade |
| aortic valve morphogenesis |
| negative regulation of biomineral tissue development |
| negative regulation of biomineralization |
| homeostasis of number of cells within a tissue |
| lung epithelium development |
| chondrocyte differentiation involved in endochondral bone morphogenesis |
| metanephric nephron development |
| aortic valve development |
| smooth muscle cell differentiation |
| positive regulation of cartilage development |
| regulation of mesenchymal cell proliferation |
| positive regulation of morphogenesis of an epithelium |
| endocardial cushion morphogenesis |
| semi-lunar valve development |
| endocrine pancreas development |
| protein kinase B signaling |
| regulation of extracellular matrix organization |
| positive regulation of kidney development |
| regulation of heart morphogenesis |
| prostate gland development |
| negative regulation of epithelial cell differentiation |
| regulation of pri-miRNA transcription by RNA polymerase II |
| exocrine system development |
| endocardial cushion development |
| chondrocyte development |
| lung morphogenesis |
| cellular response to epidermal growth factor stimulus |
| branching involved in ureteric bud morphogenesis |
| cartilage development involved in endochondral bone morphogenesis |
| eye photoreceptor cell differentiation |
| response to epidermal growth factor |
| retina morphogenesis in camera-type eye |
| mesenchyme morphogenesis |
| epidermal growth factor receptor signaling pathway |
| cochlea development |
| regulation of chondrocyte differentiation |
| heart valve morphogenesis |
| regulation of myoblast differentiation |
| ureteric bud morphogenesis |
| astrocyte differentiation |
| mesonephric tubule morphogenesis |
| regulation of kidney development |
| regulation of morphogenesis of a branching structure |
| neural retina development |
| photoreceptor cell differentiation |
| positive regulation of epithelial cell differentiation |
| heart valve development |
| nephron tubule morphogenesis |
| somatic stem cell population maintenance |
| nephron epithelium morphogenesis |
| nephron morphogenesis |
| renal tubule morphogenesis |
| oligodendrocyte differentiation |
| cellular response to retinoic acid |
| epithelial to mesenchymal transition |
| regulation of cartilage development |
| ERBB signaling pathway |
| hair follicle development |
| endochondral bone morphogenesis |
| pancreas development |
| digestive system process |
| skin epidermis development |
| negative regulation of ossification |
| hair cycle process |
| regulation of bone mineralization |
| molting cycle process |
| nephron tubule development |
| positive regulation of reproductive process |
| neural crest cell development |
| cellular response to mechanical stimulus |
| renal tubule development |
| positive regulation of animal organ morphogenesis |
| chondrocyte differentiation |
| beta-catenin binding |
| mesenchymal cell development |
| metanephros development |
| stem cell development |
| kidney morphogenesis |
| positive regulation of phosphatidylinositol 3-kinase signaling |
| ureteric bud development |
| epithelial cell proliferation |
| mesonephric tubule development |
| mesonephric epithelium development |
| developmental cell growth |
| cell fate specification |
| neural crest cell differentiation |
| cell growth |
| mesonephros development |
| hair cycle |
| molting cycle |
| regulation of biomineral tissue development |
| regulation of biomineralization |
| organ growth |
| nephron epithelium development |
| inner ear morphogenesis |
| gland morphogenesis |
| cellular response to BMP stimulus |
| response to BMP |
| response to retinoic acid |
| digestion |
| camera-type eye morphogenesis |
| bone morphogenesis |
| developmental growth involved in morphogenesis |
| nucleosome assembly |
| regulation of stem cell differentiation |
| ear morphogenesis |
| regulation of phosphatidylinositol 3-kinase signaling |
| endocrine system development |
| embryonic epithelial tube formation |
| negative regulation of epithelial cell proliferation |
| nephron development |
| liver development |
| Notch signaling pathway |
| mammary gland development |
| hepaticobiliary system development |
| kidney epithelium development |
| branching morphogenesis of an epithelial tube |
| epithelial tube formation |
| chromatin assembly |
| male gonad development |
| stem cell population maintenance |
| development of primary male sexual characteristics |
| maintenance of cell number |
| retina development in camera-type eye |
| positive regulation of epithelial cell migration |
| regulation of epithelial cell differentiation |
| morphogenesis of embryonic epithelium |
| tube formation |
| eye morphogenesis |
| cAMP-mediated signaling |
| limb morphogenesis |
| appendage morphogenesis |
| cellular response to transforming growth factor beta stimulus |
| chromatin assembly or disassembly |
| mesenchymal cell differentiation |
| nucleosome organization |
| male sex differentiation |
| stem cell differentiation |
| morphogenesis of a branching epithelium |
| regulation of reproductive process |
| chromatin remodeling |
| protein localization to nucleus |
| response to transforming growth factor beta |
| morphogenesis of a branching structure |
| lung development |
| glial cell differentiation |
| cartilage development |
| cyclic-nucleotide-mediated signaling |
| respiratory tube development |
| cellular response to interleukin-1 |
| negative regulation of canonical Wnt signaling pathway |
| transcription initiation from RNA polymerase II promoter |
| DNA packaging |
| limb development |
| regulation of morphogenesis of an epithelium |
| appendage development |
| positive regulation of epithelial cell proliferation |
| tissue homeostasis |
| regulation of ossification |
| epithelial cell development |
| inner ear development |
| respiratory system development |
| response to interleukin-1 |
| homeostasis of number of cells |
| bone development |
| protein-DNA complex assembly |
| cellular response to acid chemical |
| negative regulation of Wnt signaling pathway |
| gonad development |
| response to mechanical stimulus |
| gliogenesis |
| DNA-templated transcription, initiation |
| positive regulation of protein catabolic process |
| development of primary sexual characteristics |
| regulation of epithelial cell migration |
| ear development |
| mesenchyme development |
| connective tissue development |
| negative regulation of neuron differentiation |
| skeletal system morphogenesis |
| protein-DNA complex subunit organization |
| muscle cell differentiation |
| cell fate commitment |
| heart morphogenesis |
| sensory organ morphogenesis |
| regulation of animal organ morphogenesis |
| ossification |
| sex differentiation |
| kidney development |
| regulation of canonical Wnt signaling pathway |
| renal system development |
| embryonic organ morphogenesis |
| negative regulation of neurogenesis |
| muscle tissue development |
| DNA conformation change |
| epithelial tube morphogenesis |
| negative regulation of nervous system development |
| camera-type eye development |
| cellular response to environmental stimulus |
| cellular response to abiotic stimulus |
| urogenital system development |
| multicellular organismal homeostasis |
| regulation of epithelial cell proliferation |
| negative regulation of cell development |
| cellular response to external stimulus |
| second-messenger-mediated signaling |
| extracellular matrix organization |
| anatomical structure homeostasis |
| response to acid chemical |
| eye development |
| regulation of Wnt signaling pathway |
| visual system development |
| sensory system development |
| MAPK cascade |
| skin development |
| regulation of protein catabolic process |
| extracellular structure organization |
| developmental growth |
| growth |
| signal transduction by protein phosphorylation |
| chromatin binding |
| cellular response to drug |
| gland development |
| epidermis development |
| reproductive structure development |
| reproductive system development |
| positive regulation of catabolic process |
| morphogenesis of an epithelium |
| embryonic organ development |
| negative regulation of immune system process |
| DNA-binding transcription activator activity, RNA polymerase II-specific |
| muscle structure development |
| transcription by RNA polymerase II |
| protein heterodimerization activity |
| skeletal system development |
| positive regulation of cell migration |
| cellular response to growth factor stimulus |
| RNA polymerase II proximal promoter sequence-specific DNA binding |
| cell-cell adhesion |
| transmembrane receptor protein tyrosine kinase signaling pathway |
| cellular response to lipid |
| positive regulation of cellular component biogenesis |
| positive regulation of cell motility |
| heart development |
| response to growth factor |
| positive regulation of cellular component movement |
| spermatogenesis |
| sensory organ development |
| positive regulation of locomotion |
| cell population proliferation |
| male gamete generation |
| tissue morphogenesis |
| embryonic morphogenesis |
| protein-containing complex |
| cellular response to organonitrogen compound |
| chordate embryonic development |
| transcription, DNA-templated |
| nucleic acid-templated transcription |
| embryo development ending in birth or egg hatching |
| RNA biosynthetic process |
| tube morphogenesis |
| regulation of neuron differentiation |
| cellular response to nitrogen compound |
| developmental process involved in reproduction |
| negative regulation of cell population proliferation |
| DNA-binding transcription factor activity |
| epithelial cell differentiation |
| regulation of cell adhesion |
| gamete generation |
| chromatin organization |
| negative regulation of cell differentiation |
| enzyme linked receptor protein signaling pathway |
| protein localization to organelle |
| regulation of cell cycle process |
| head development |
| regulation of neurogenesis |
| multicellular organismal reproductive process |
| sexual reproduction |
| cellular protein-containing complex assembly |
| multicellular organism reproduction |
| tube development |
| regulation of cell migration |
| response to lipid |
| negative regulation of transcription by RNA polymerase II |
| circulatory system development |
| negative regulation of apoptotic process |
| anatomical structure formation involved in morphogenesis |
| negative regulation of programmed cell death |
| regulation of cell motility |
| positive regulation of cell population proliferation |
| regulation of nervous system development |
| cell adhesion |
| regulation of cell development |
| biological adhesion |
| negative regulation of developmental process |
| animal organ morphogenesis |
| regulation of cellular component biogenesis |
| positive regulation of cell differentiation |
| protein phosphorylation |
| embryo development |
| central nervous system development |
| regulation of locomotion |
| regulation of cellular component movement |
| multi-organism reproductive process |
| negative regulation of cell death |
| regulation of catabolic process |
| response to organonitrogen compound |
| cellular response to cytokine stimulus |
| neuron differentiation |
| positive regulation of protein phosphorylation |
| positive regulation of intracellular signal transduction |
| response to drug |
| cellular response to oxygen-containing compound |
| positive regulation of phosphorylation |
| regulation of anatomical structure morphogenesis |
| chromosome organization |
| response to nitrogen compound |
| nucleobase-containing compound biosynthetic process |
| response to cytokine |
| cytoskeleton organization |
| epithelium development |
| positive regulation of phosphate metabolic process |
| positive regulation of phosphorus metabolic process |
| response to abiotic stimulus |
| heterocycle biosynthetic process |
| aromatic compound biosynthetic process |
| regulation of cell cycle |
| negative regulation of transcription, DNA-templated |
| negative regulation of multicellular organismal process |
| positive regulation of cellular component organization |
| positive regulation of transcription by RNA polymerase II |
| cellular response to endogenous stimulus |
| positive regulation of protein modification process |
| negative regulation of nucleic acid-templated transcription |
| negative regulation of RNA biosynthetic process |
| negative regulation of signal transduction |
| phosphorylation |
| organic cyclic compound biosynthetic process |
| negative regulation of RNA metabolic process |
| negative regulation of cell communication |
| negative regulation of signaling |
| positive regulation of developmental process |
| negative regulation of cellular macromolecule biosynthetic process |
| reproductive process |
| reproduction |
| negative regulation of nucleobase-containing compound metabolic process |
| regulation of protein phosphorylation |
| negative regulation of macromolecule biosynthetic process |
| response to endogenous stimulus |
| negative regulation of cellular biosynthetic process |
| generation of neurons |
| regulation of apoptotic process |
| positive regulation of transcription, DNA-templated |
| negative regulation of biosynthetic process |
| response to oxygen-containing compound |
| protein-containing complex assembly |
| DNA-binding transcription factor activity, RNA polymerase II-specific |
| regulation of programmed cell death |
| cellular protein localization |
| regulation of phosphorylation |
| cellular macromolecule localization |
| positive regulation of cellular protein metabolic process |
| regulation of cell population proliferation |
| negative regulation of response to stimulus |
| neurogenesis |
| cellular nitrogen compound biosynthetic process |
| positive regulation of nucleic acid-templated transcription |
| positive regulation of RNA biosynthetic process |
| homeostatic process |
| cell development |
| positive regulation of signal transduction |
| regulation of immune system process |
| RNA metabolic process |
| regulation of cell death |
| intracellular signal transduction |
| positive regulation of protein metabolic process |
| cellular macromolecule biosynthetic process |
| negative regulation of gene expression |
| positive regulation of RNA metabolic process |
| positive regulation of multicellular organismal process |
| tissue development |
| macromolecule biosynthetic process |
| regulation of phosphate metabolic process |
| regulation of phosphorus metabolic process |
| regulation of cell differentiation |
| positive regulation of cell communication |
| positive regulation of signaling |
| regulation of intracellular signal transduction |
| regulation of protein modification process |
| protein-containing complex subunit organization |
| positive regulation of nucleobase-containing compound metabolic process |
| positive regulation of macromolecule biosynthetic process |
| system process |
| positive regulation of cellular biosynthetic process |
| positive regulation of gene expression |
| gene expression |
| positive regulation of biosynthetic process |
Compound Hit Most Correlated Genes in Chemogenomics Tissues where Essential in the Avana Dataset (DepMap 20Q1)
| Tissue | Fraction Of Cell Lines Where Essential |
|---|---|
| 1290807.0 | 0/1 |
| 909776.0 | 0/1 |
| bile duct | 3/28 |
| blood | 0/28 |
| bone | 2/26 |
| breast | 1/33 |
| central nervous system | 0/56 |
| cervix | 0/4 |
| colorectal | 3/17 |
| esophagus | 0/13 |
| fibroblast | 0/1 |
| gastric | 3/16 |
| kidney | 0/21 |
| liver | 0/20 |
| lung | 1/75 |
| lymphocyte | 0/16 |
| ovary | 0/26 |
| pancreas | 2/24 |
| peripheral nervous system | 0/16 |
| plasma cell | 0/15 |
| prostate | 0/1 |
| skin | 2/24 |
| soft tissue | 0/9 |
| thyroid | 0/2 |
| upper aerodigestive | 0/22 |
| urinary tract | 2/29 |
| uterus | 0/5 |
Expression Distribution